NCT04898686View on ClinicalTrials.gov

Probiotic Chewables in Allergic Rhinoconjunctivitis Patients

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

August 6, 2021

Study Completion Date

August 6, 2021

Conditions
Allergic Rhinoconjunctivitis
Interventions
BIOLOGICAL

Probiotic chewables

chewables containing Lacticaseibacillus rhamnosus GG

BIOLOGICAL

Placebo chewables

chewables without probiotic strain. Ingredients: Xylitol, microcrystalline cellulose, stearic acid, natural orange flavor, silica, magnesium stearate, citric acid and malic acid.

Trial Locations (1)

Unknown

Antwerp University Hospital, Edegem

All Listed Sponsors
collaborator

DSM Nutritional Products, Inc.

INDUSTRY

lead

University Hospital, Antwerp

OTHER

NCT04898686 - Probiotic Chewables in Allergic Rhinoconjunctivitis Patients | Biotech Hunter | Biotech Hunter